epcam-targeted car-t
sino bioway
['gastric', ' epcam', 'rectal', 'colorectal']
imc001, an investigational car-t therapy which targets epcam, has demonstrated a favorable safety profile and promising anti-tumor activities in patients with advanced colorectal and gastric cancers, according to data presented at #esmo2022 read more: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.